Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
D000293:Adolescent; D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002699:Chlorambucil / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D009447:Neuroblastoma / Q000188:drug therapy; D011238:Prednimustine / Q000008:administration & dosage* / Q000627:therapeutic use
D002699:Chlorambucil; D011238:Prednimustine